DXCM Q2 2018 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$26B

Q2 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$243M+42.1% YoY

Gross Profit

$154M63.3% margin

Operating Income

-$5M-2.0% margin

Net Income

$30M12.5% margin

EPS (Diluted)

$0.09

QoQ Revenue Growth

+31.5%

Cash Flow

Operating Cash Flow

$41M

Free Cash Flow

$31M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$525M

Stockholders' Equity

$482M

Cash & Equivalents

$300M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$243M	$171M	+42.1%
Gross Profit	$154M	$118M	+30.7%
Operating Income	-$5M	-$14M	+64.0%
Net Income	$30M	$3M	+941.4%

Geographic Segments

UNITED STATES

$190M78%

Non-US

$53M22%